These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8105384)

  • 1. Impact of drug regulations and diversion control systems on legitimate narcolepsy patients.
    Piscopo JA
    NIDA Res Monogr; 1993; 131():249-59. PubMed ID: 8105384
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gammahydroxybutyrate must remain available for patients with narcolepsy].
    Lammers GJ; van Dijk JG; Ferrari MD; van Gerven JM; Declerck AC; Troost J
    Ned Tijdschr Geneeskd; 1999 Oct; 143(41):2062-3. PubMed ID: 10560549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the new drug provisions on the drug treatment of narcolepsy].
    Mayer G
    Dtsch Med Wochenschr; 2004 May; 129(21):1198-201. PubMed ID: 15160324
    [No Abstract]   [Full Text] [Related]  

  • 4. Summary and conclusions of a review of prescription drug diversion control methods.
    Horgan C; Prottas J; Tompkins C; Wastila L; Bowden M
    NIDA Res Monogr; 1993; 131():206-23. PubMed ID: 8413532
    [No Abstract]   [Full Text] [Related]  

  • 5. Time to update Uniform Controlled Substances Act.
    Jefferson JW
    Wis Med J; 1997 May; 96(5):8. PubMed ID: 9214154
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of prescription drug control systems on medical practice and patient care: a summary of the NIDA technical review.
    NIDA Res Monogr; 1993; 131():1-17. PubMed ID: 8413519
    [No Abstract]   [Full Text] [Related]  

  • 7. Diversion investigation units--methods, utilities, and limitations.
    Bulla RK
    NIDA Res Monogr; 1993; 131():145-50. PubMed ID: 8413525
    [No Abstract]   [Full Text] [Related]  

  • 8. An American Medical Association perspective on preventing prescription drug diversion.
    Ambre JJ
    NIDA Res Monogr; 1993; 131():224-7. PubMed ID: 8413533
    [No Abstract]   [Full Text] [Related]  

  • 9. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances.
    Joranson DE
    NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529
    [No Abstract]   [Full Text] [Related]  

  • 10. Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations.
    Weintraub M; Singh S; Byrne L; Maharaj K; Guttmacher L
    NIDA Res Monogr; 1993; 131():279-93. PubMed ID: 8105386
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of d-amphetamine and related central nervous system stimulants in children.
    Pediatrics; 1973 Feb; 51(2):302-5. PubMed ID: 4695865
    [No Abstract]   [Full Text] [Related]  

  • 12. Issuance of multiple prescriptions for schedule II controlled substances. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2007 Nov; 72(222):64921-30. PubMed ID: 18038486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleepless in America.
    Gorman C
    Time; 2001 Dec; 158(26):88. PubMed ID: 11778569
    [No Abstract]   [Full Text] [Related]  

  • 14. The prescription of controlled substances: what's right and what's wrong.
    Cohen S
    NIDA Res Monogr; 1979; 27():11-6. PubMed ID: 44892
    [No Abstract]   [Full Text] [Related]  

  • 15. Dentistry: controlled substances and enforcement.
    Hankins HH
    Ark Dent J; 1979 Jun; 50(2):12-5. PubMed ID: 119520
    [No Abstract]   [Full Text] [Related]  

  • 16. Dear DEA.
    Heit HA; Covington E; Good PM
    Pain Med; 2004 Sep; 5(3):303-8. PubMed ID: 15367311
    [No Abstract]   [Full Text] [Related]  

  • 17. The DEA proposes schedule II substance rule.
    Buchanan BL
    WMJ; 2007 Jul; 106(4):230. PubMed ID: 17844715
    [No Abstract]   [Full Text] [Related]  

  • 18. Triplicate prescription: issues and answers. Introduction.
    Farnsworth PB
    N Y State J Med; 1991 Nov; 91(11 Suppl):1S-4S. PubMed ID: 1771052
    [No Abstract]   [Full Text] [Related]  

  • 19. Exemption from import/export requirements for personal medical use. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2004 Sep; 69(177):55343-7. PubMed ID: 15366181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug diversion control systems, medical practice, and patient care.
    Haislip GR
    NIDA Res Monogr; 1993; 131():120-31. PubMed ID: 8413522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.